Notice of Listing of Members of the Food and Drug Administration's Performance Review Board, 85580 [2016-28452]

Download as PDF 85580 Federal Register / Vol. 81, No. 228 / Monday, November 28, 2016 / Notices Dated: November 21, 2016. Leslie Kux, Associate Commissioner for Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Service Administration [FR Doc. 2016–28443 Filed 11–25–16; 8:45 am] BILLING CODE 4164–01–P Advisory Committee on Interdisciplinary, Community-Based Linkages DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Service Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: Food and Drug Administration [Docket No. FDA–2011–N–0769] Notice of Listing of Members of the Food and Drug Administration’s Performance Review Board AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing the names of the members who will serve on its Performance Review Board (PRB). The purpose of the PRB is to provide fair and impartial review of senior executive service (SES), senior professional and Title 42 SES Equivalents performance appraisals, bonus recommendations, and pay adjustments. SUMMARY: DATES: Effective November 7, 2016. Abu Sesay, Office of Human Resources Executive and Resources Management Staff, Food and Drug Administration, Three White Flint North, 05D04, 11601 Landsdown St., North Bethesda, MD 20852, 240–402–0440, abu.sesay@ fda.hhs.gov. FOR FURTHER INFORMATION CONTACT: This action is being taken pursuant to 5 U.S.C. 4314(c)(4), which requires that members of performance review boards be appointed in a manner to ensure consistency, stability, and objectivity in performance appraisals and requires that notice of the appointment of an individual to serve as a member be published in the Federal Register. The following persons will serve on FDA’s Performance Review Board, which oversees the evaluation of performance appraisals of FDA’s senior executives: James Sigg, PRB Chair and member; Tania Tse, PRB Officiator; Glenda Barfell; Vincent Bunning; Mary Beth Clarke; Tracey Forfa; Leslie Kux; Deanna Murphy; Lynne Rice; and Richard Turman. mstockstill on DSK3G9T082PROD with NOTICES SUPPLEMENTARY INFORMATION: Dated: November 21, 2016. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2016–28452 Filed 11–25–16; 8:45 am] BILLING CODE 4164–01–P VerDate Sep<11>2014 21:15 Nov 25, 2016 Jkt 241001 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given that a meeting is scheduled for Advisory Committee on Interdisciplinary, Community-Based Linkages (ACICBL). This meeting will be open to the public. Information about the ACICBL and the agenda for this meeting can be obtained by accessing the following Web site: http:// www.hrsa.gov/advisorycommittees/ bhpradvisory/acicbl/index.html. The agenda will be available 2 days prior to the meeting on the HRSA Web site listed above. DATES: The meeting will be held on December 8, 2016 (10:00 a.m.–4:00 p.m.). SUMMARY: This meeting will be held via webinar and teleconference. Webinar information can be found on the Web site at: https:// hrsa.connectsolutions.com/acicbl and below. • The conference call-in number is 1– 800–619–2521. The passcode is: 9271697. • The Webinar link is https:// hrsa.connectsolutions.com/acicbl. FOR FURTHER INFORMATION CONTACT: Anyone requesting information regarding the ACICBL should contact Dr. Joan Weiss, Designated Federal Official, within the Bureau of Health Workforce, Health Resources and Services Administration, in one of three ways: (1) Send a request to the following address: Dr. Joan Weiss, Designated Federal Official, Bureau of Health Workforce, Health Resources and Services Administration, 5600 Fishers Lane, Room 15N39, Rockville, Maryland 20857; (2) call (301) 443–0430; or (3) send an email to jweiss@hrsa.gov. SUPPLEMENTARY INFORMATION: The ACICBL provides advice and recommendations to the Secretary of HHS (Secretary) concerning policy, program development, and other matters of significance related to interdisciplinary, community-based training grant programs authorized ADDRESSES: PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 under sections 750–759, Title VII, Part D of the Public Health Service (PHS) Act, as amended by the Affordable Care Act. The following sections of the PHS Act are included under Part D: 751— Area Health Education Centers; 752— Continuing Educational Support for Health Professionals Serving in Underserved Communities; 753— Geriatrics Workforce Enhancement; 754—Quentin N. Burdick Program for Rural Interdisciplinary Training; 755— Allied Health and Other Disciplines; 756—Mental and Behavioral Health Education and Training, and 759— Program for Education and Training in Pain Care. Per the PHS Act section 757(d)(2), the Committee is responsible for publishing an annual report describing ‘‘the activities of the Committee, including findings and recommendations made by the Committee concerning the activities under this part.’’ The members of the ACICBL will discuss how they would like to proceed with and structure the statutorily mandated 17th report. They will also finalize the statutorily mandated 16th Annual Report to the Secretary and Congress on ‘‘Enhancing Community-Based Training Sites: Challenges and Opportunities.’’ Members of the public will have the opportunity to provide comments. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to make oral comments or provide written comments to the ACICBL should be sent to Dr. Joan Weiss, Designated Federal Official, using the address and phone number above at least 3 days prior to the meeting. Jason E. Bennett, Director, Division of the Executive Secretariat. [FR Doc. 2016–28469 Filed 11–25–16; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Decision To Evaluate a Petition To Designate a Class of Employees From Metals & Controls Corp. in Attleboro, Massachusetts, To Be Included in the Special Exposure Cohort National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, Department of Health and Human Services. ACTION: Notice. AGENCY: NIOSH gives notice of a decision to evaluate a petition to designate a class of employees from Metals & Controls Corp. in Attleboro, SUMMARY: E:\FR\FM\28NON1.SGM 28NON1

Agencies

[Federal Register Volume 81, Number 228 (Monday, November 28, 2016)]
[Notices]
[Page 85580]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-28452]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0769]


Notice of Listing of Members of the Food and Drug 
Administration's Performance Review Board

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the names 
of the members who will serve on its Performance Review Board (PRB). 
The purpose of the PRB is to provide fair and impartial review of 
senior executive service (SES), senior professional and Title 42 SES 
Equivalents performance appraisals, bonus recommendations, and pay 
adjustments.

DATES: Effective November 7, 2016.

FOR FURTHER INFORMATION CONTACT: Abu Sesay, Office of Human Resources 
Executive and Resources Management Staff, Food and Drug Administration, 
Three White Flint North, 05D04, 11601 Landsdown St., North Bethesda, MD 
20852, 240-402-0440, abu.sesay@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: This action is being taken pursuant to 5 
U.S.C. 4314(c)(4), which requires that members of performance review 
boards be appointed in a manner to ensure consistency, stability, and 
objectivity in performance appraisals and requires that notice of the 
appointment of an individual to serve as a member be published in the 
Federal Register.
    The following persons will serve on FDA's Performance Review Board, 
which oversees the evaluation of performance appraisals of FDA's senior 
executives: James Sigg, PRB Chair and member; Tania Tse, PRB 
Officiator; Glenda Barfell; Vincent Bunning; Mary Beth Clarke; Tracey 
Forfa; Leslie Kux; Deanna Murphy; Lynne Rice; and Richard Turman.

    Dated: November 21, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-28452 Filed 11-25-16; 8:45 am]
 BILLING CODE 4164-01-P